Indivior Pharmaceuticals, Inc. (INDV) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jack A. Khattar

Chief Executive Officer

—

3,413,555

2.89%

$121.83M

—

Joseph Ciaffoni

Chief Executive Officer

—

790,330

0.6697%

$28.21M

+1,311%

Ryan Preblick

Chief Financial Officer

—

284,751

0.2413%

$10.16M

+1.5%

Christian Heidbreder

Chief Scientific Officer

—

209,337

0.1774%

$7.47M

+33.2%

Jeffrey W Burris

Chief Legal Officer

—

71,518

0.0606%

$2.55M

+9,310%

Georges Gemayel

Director

—

42,009

0.0356%

$1.50M

—

Carrolee Barlow

Director

—

41,652

0.0353%

$1.49M

—

Patrick A Barry

Chief Commercial Officer

—

31,380

0.0266%

$1.12M

—

David E. Wheadon

Director

—

30,780

0.0261%

$1.10M

+143.8%

Frank Mottola

SVP, Chief Tech. Ops. Officer

—

30,099

0.0255%

$1.07M

—

Padmanabh P. Bhatt

SVP of IP, CSO

—

28,702

0.0243%

$1.02M

—

Woodrow D Anderson

Chief Accounting Officer

—

27,638

0.0234%

$986.40K

+529.6%

Daniel A Ninivaggi

Director

—

27,163

0.0230%

$969.45K

+68.2%

Mark Stejbach

Director

—

27,087

0.0230%

$966.74K

+68.5%

Jonathan Rubin

SVP, Chief Medical Officer

—

21,529

0.0182%

$768.37K

—

Keith Humphreys

Director

—

16,042

0.0136%

$572.54K

+219.1%

Timothy C Dec

SVP, Chief Financial Officer

—

14,059

0.0119%

$501.77K

—

Juliet Thompson

Director

—

12,973

0.0110%

$463.01K

+237.0%

Barbara Ryan

Director

—

12,242

0.0104%

$436.92K

+930.5%

Stuart A Kingsley

Director

—

12,100

0.0103%

$431.85K

+1,215%

Indivior Pharmaceuticals, Inc.

What the insiders did No buying or selling

By person